![Curis Inc](/common/images/company/N_CRIS.png)
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others... Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Show more
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass., July 10, 2024 LEXINGTON, Mass., July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology...
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., July 8, 2024 LEXINGTON, Mass., July 8, 2024 /PRNewswire/ --Β Curis, Inc. (NASDAQ: CRIS), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.485 | -7.0802919708 | 6.85 | 7.1203 | 6.07 | 23624 | 6.44282145 | CS |
4 | -1.415 | -18.1876606684 | 7.78 | 8 | 6.0679 | 26537 | 6.71135924 | CS |
12 | -9.095 | -58.82923674 | 15.46 | 16.99 | 6.0679 | 29385 | 9.35957953 | CS |
26 | -5.035 | -44.1666666667 | 11.4 | 17.49 | 6.0679 | 31811 | 10.74876908 | CS |
52 | -9.635 | -60.21875 | 16 | 17.49 | 3.8 | 101275 | 10.87503052 | CS |
156 | -144.035 | -95.7679521277 | 150.4 | 180.8 | 3.8 | 1088963 | 48.24593713 | CS |
260 | -41.635 | -86.7395833333 | 48 | 348 | 3.8 | 1566921 | 97.06213325 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.